Top entities: BIO-key International, Nasdaq-100, United States — United States Securities and Exchange Commission.

What category does this event fall under?

Regulatory — classified as non-compliance notification.

What is the sentiment of coverage?

Aggregate sentiment score: -60 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

What were the key actions taken?

Nasdaq-100 issued notification letter BIO-key International · BIO-key International failed to file United States — United States Securities and Exchange Commission

Is this event still developing?

This is an active story, last updated Jun 10, 2026. Coverage continues to evolve.

Regulatory non-compliance notification

BIO-key Nasdaq non-compliance

Q: When did this event occur?

First reported Apr 20, 2026; last updated Jun 10, 2026.

Q: What is the market impact?

Direct. The market is negatively impacted as BIO-key International faces potential delisting from Nasdaq-100, which could lead to a further decline in its stock price and investor confidence.

Analysis based on 7 articles · First reported Apr 20, 2026 · Last updated Jun 10, 2026

Sentiment

-60

Attention

Articles

Market Impact

Direct

Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

Market Impact

The market is negatively impacted as BIO-key International faces potential delisting from Nasdaq-100, which could lead to a further decline in its stock price and investor confidence. This event highlights regulatory risks for companies failing to meet filing requirements.

Technology Cybersecurity

Event Summary

BIO-key International, a global leader in Identity and Access Management and biometric authentication technologies, received a notification from Nasdaq-100 for non-compliance with Listing Rule 5250(c)(1). This rule requires timely filing of periodic financial reports with the United States — United States Securities and Exchange Commission. The non-compliance stems from BIO-key International's failure to file its Quarterly Report on Form 10-Q for the period ended March 31, 2026. The Nasdaq-100 Hearing Panel will consider this matter in determining BIO-key International's continued listing on the Nasdaq-100 Capital Market. This development follows a 41% decline in BIO-key International's stock over the past six months.

Key Actions

95 Nasdaq-100 issued notification letter BIO-key International

90 BIO-key International failed to file United States — United States Securities and Exchange Commission

Entities Involved

stock

BIO-key International

BIO-key International received a non-compliance notification from The Nasdaq-100 Stock Market, LLC for failing to timely file its Quarterly Report on Form 10-Q, which could lead to delisting from the Nasdaq-100 Capital Market. Its stock has declined 41% over the past six months.

Importance 100 Sentiment -70

index

Nasdaq-100

Nasdaq-100 issued a non-compliance notification to BIO-key International and its Hearing Panel will determine the company's continued listing status.

Importance 80 Sentiment 0

govactor

United States — United States Securities and Exchange Commission

The United States — United States Securities and Exchange Commission is the regulatory body with which BIO-key International failed to file its required periodic financial reports.

Importance 30 Sentiment 0

NEWSDESK

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard